Tomohide Yamada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomohide Yamada has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Nobuhiro Shojima
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
7 shared publicationsTakashi Kadowaki
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
6 shared publicationsHisashi Noma
Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan
5 shared publications- Nobuhiro Shojima
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine The University of Tokyo Tokyo Japan
5 shared publications Toshimasa Yamauchi
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
5 shared publications- Ryo Momosaki
Department of Rehabilitation, Mie University Hospital, Mie, Japan
4 shared publications
Latest Publications
- Open Access
Comparison of machine-learning and logistic regression models to predict 30-day unplanned readmission: a development and validation study
We compared the predictive performance of gradient-boosted decision tree (GBDT), random forest (RF), deep neural network (DNN), and logistic regression (LR) with the least absolute shrinkage and selection operator (LASSO) for 30-day unplanned readmission, according to the number of predictor variables and presence/absence of blood-test results. We used electronic health records of patients discharged alive from 38 hospitals in 2015–2017 for derivation (n=339,513) and in 2018 for validation (n=118,074), including basic characteristics (age, sex, admission diagnosis category, number of hospitalizations in the past year, discharge location), diagnosis, surgery, procedure, and drug codes, and blood-test results. We created six patterns of datasets having different numbers of binary variables (that ≥5% or ≥1% of patients or ≥10 patients had) with and without blood-test results. For the dataset with the smallest number of variables (102), the c-statistic was highest for GBDT (0.740), followed by RF (0.734), LR-LASSO (0.720), and DNN (0.664). For the dataset with the largest number of variables (1543), the c-statistic was highest for GBDT (0.764), followed by LR-LASSO (0.755), RF (0.751), and DNN (0.720). We found that GBDT generally outperformed LR-LASSO, but the difference became smaller when the number of variables was increased and blood-test results were used.
Open AccessComparison of machine-learning and logistic regression models to predict 30-day unplanned readmission: a development and validation study
We compared the predictive performance of gradient-boosted decision tree (GBDT), random forest (RF), deep neural network (DNN), and logistic regression (LR) with the least absolute shrinkage and selection operator (LASSO) for 30-day unplanned readmission, according to the number of predictor variables and presence/absence of blood-test results. We used electronic health records of patients discharged alive from 38 hospitals in 2015–2017 for derivation (n=339,513) and in 2018 for validation (n=118,074), including basic characteristics (age, sex, admission diagnosis category, number of hospitalizations in the past year, discharge location), diagnosis, surgery, procedure, and drug codes, and blood-test results. We created six patterns of datasets having different numbers of binary variables (that ≥5% or ≥1% of patients or ≥10 patients had) with and without blood-test results. For the dataset with the smallest number of variables (102), the c-statistic was highest for GBDT (0.740), followed by RF (0.734), LR-LASSO (0.720), and DNN (0.664). For the dataset with the largest number of variables (1543), the c-statistic was highest for GBDT (0.764), followed by LR-LASSO (0.755), RF (0.751), and DNN (0.720). We found that GBDT generally outperformed LR-LASSO, but the difference became smaller when the number of variables was increased and blood-test results were used.
- Open Access
- 30 April 2021
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (9) , e3673-e3681
FTO Obesity Variant–Exercise Interaction on Changes in Body Weight and BMI: The Taiwan Biobank Study
Context Gene–exercise interaction on cross-sectional body mass index (BMI) has been extensively studied and is well established. However, gene–exercise interaction on changes in body weight/BMI remains controversial. Objective To examine the interaction between the FTO obesity variant and regular exercise on changes in body weight/BMI. Participants Taiwan Biobank participants aged 30-70 years (N = 20 906) were examined at both baseline and follow-up visit (mean follow-up duration: 3.7 years). Main Outcome Measures The interaction between the FTO obesity variant rs1421085 and regular exercise habit (no exercise, ≤20 metabolic equivalent of tasks (METs)/week exercise, >20 METs/week exercise) on changes in body weight/BMI. Results Individuals with the risk allele of rs1421085 gained more weight and increased BMI than those without the risk allele if they did not exercise. In contrast, individuals with the risk allele gained less weight and BMI if they exercised regularly, indicating an interaction between rs1421085 and regular exercise habit (P = .030 for Δbody weight and P = .034 for ΔBMI). The effect of exercise on maintaining body weight was larger in those with the risk allele of rs1421085. When we focused on individuals without regular exercise at baseline, individuals with the risk allele again tended to lose more weight than those with a nonrisk allele if they had acquired an exercise habit by the follow-up visit. Conclusion The beneficial effect of exercise is greater in individuals genetically prone to obesity due to the interaction between the FTO obesity variant rs1421085 and regular exercise on changes in body weight and BMI.
- 30 April 2021
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (9) , e3673-e3681
Open AccessFTO Obesity Variant–Exercise Interaction on Changes in Body Weight and BMI: The Taiwan Biobank Study
Context Gene–exercise interaction on cross-sectional body mass index (BMI) has been extensively studied and is well established. However, gene–exercise interaction on changes in body weight/BMI remains controversial. Objective To examine the interaction between the FTO obesity variant and regular exercise on changes in body weight/BMI. Participants Taiwan Biobank participants aged 30-70 years (N = 20 906) were examined at both baseline and follow-up visit (mean follow-up duration: 3.7 years). Main Outcome Measures The interaction between the FTO obesity variant rs1421085 and regular exercise habit (no exercise, ≤20 metabolic equivalent of tasks (METs)/week exercise, >20 METs/week exercise) on changes in body weight/BMI. Results Individuals with the risk allele of rs1421085 gained more weight and increased BMI than those without the risk allele if they did not exercise. In contrast, individuals with the risk allele gained less weight and BMI if they exercised regularly, indicating an interaction between rs1421085 and regular exercise habit (P = .030 for Δbody weight and P = .034 for ΔBMI). The effect of exercise on maintaining body weight was larger in those with the risk allele of rs1421085. When we focused on individuals without regular exercise at baseline, individuals with the risk allele again tended to lose more weight than those with a nonrisk allele if they had acquired an exercise habit by the follow-up visit. Conclusion The beneficial effect of exercise is greater in individuals genetically prone to obesity due to the interaction between the FTO obesity variant rs1421085 and regular exercise on changes in body weight and BMI.
- Open Access
- 30 December 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (12) , e22422
Deep Neural Network for Reducing the Screening Workload in Systematic Reviews for Clinical Guidelines: Algorithm Validation Study
Background: Performing systematic reviews is a time-consuming and resource-intensive process. Objective: We investigated whether a machine learning system could perform systematic reviews more efficiently. Methods: All systematic reviews and meta-analyses of interventional randomized controlled trials cited in recent clinical guidelines from the American Diabetes Association, American College of Cardiology, American Heart Association (2 guidelines), and American Stroke Association were assessed. After reproducing the primary screening data set according to the published search strategy of each, we extracted correct articles (those actually reviewed) and incorrect articles (those not reviewed) from the data set. These 2 sets of articles were used to train a neural network–based artificial intelligence engine (Concept Encoder, Fronteo Inc). The primary endpoint was work saved over sampling at 95% recall (WSS@95%). Results: Among 145 candidate reviews of randomized controlled trials, 8 reviews fulfilled the inclusion criteria. For these 8 reviews, the machine learning system significantly reduced the literature screening workload by at least 6-fold versus that of manual screening based on WSS@95%. When machine learning was initiated using 2 correct articles that were randomly selected by a researcher, a 10-fold reduction in workload was achieved versus that of manual screening based on the WSS@95% value, with high sensitivity for eligible studies. The area under the receiver operating characteristic curve increased dramatically every time the algorithm learned a correct article. Conclusions: Concept Encoder achieved a 10-fold reduction of the screening workload for systematic review after learning from 2 randomly selected studies on the target topic. However, few meta-analyses of randomized controlled trials were included. Concept Encoder could facilitate the acquisition of evidence for clinical guidelines.
- 30 December 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (12) , e22422
Open AccessDeep Neural Network for Reducing the Screening Workload in Systematic Reviews for Clinical Guidelines: Algorithm Validation Study
Background: Performing systematic reviews is a time-consuming and resource-intensive process. Objective: We investigated whether a machine learning system could perform systematic reviews more efficiently. Methods: All systematic reviews and meta-analyses of interventional randomized controlled trials cited in recent clinical guidelines from the American Diabetes Association, American College of Cardiology, American Heart Association (2 guidelines), and American Stroke Association were assessed. After reproducing the primary screening data set according to the published search strategy of each, we extracted correct articles (those actually reviewed) and incorrect articles (those not reviewed) from the data set. These 2 sets of articles were used to train a neural network–based artificial intelligence engine (Concept Encoder, Fronteo Inc). The primary endpoint was work saved over sampling at 95% recall (WSS@95%). Results: Among 145 candidate reviews of randomized controlled trials, 8 reviews fulfilled the inclusion criteria. For these 8 reviews, the machine learning system significantly reduced the literature screening workload by at least 6-fold versus that of manual screening based on WSS@95%. When machine learning was initiated using 2 correct articles that were randomly selected by a researcher, a 10-fold reduction in workload was achieved versus that of manual screening based on the WSS@95% value, with high sensitivity for eligible studies. The area under the receiver operating characteristic curve increased dramatically every time the algorithm learned a correct article. Conclusions: Concept Encoder achieved a 10-fold reduction of the screening workload for systematic review after learning from 2 randomly selected studies on the target topic. However, few meta-analyses of randomized controlled trials were included. Concept Encoder could facilitate the acquisition of evidence for clinical guidelines.
- Open Access
- 14 July 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Deep Neural Network for Reducing the Screening Workload in Systematic Reviews for Clinical Guidelines: Algorithm Validation Study (Preprint)
BACKGROUND Performing systematic reviews is a time-consuming and resource-intensive process. OBJECTIVE We investigated whether a machine learning system could perform systematic reviews more efficiently. METHODS All systematic reviews and meta-analyses of interventional randomized controlled trials cited in recent clinical guidelines from the American Diabetes Association, American College of Cardiology, American Heart Association (2 guidelines), and American Stroke Association were assessed. After reproducing the primary screening data set according to the published search strategy of each, we extracted correct articles (those actually reviewed) and incorrect articles (those not reviewed) from the data set. These 2 sets of articles were used to train a neural network–based artificial intelligence engine (Concept Encoder, Fronteo Inc). The primary endpoint was work saved over sampling at 95% recall (WSS@95%). RESULTS Among 145 candidate reviews of randomized controlled trials, 8 reviews fulfilled the inclusion criteria. For these 8 reviews, the machine learning system significantly reduced the literature screening workload by at least 6-fold versus that of manual screening based on WSS@95%. When machine learning was initiated using 2 correct articles that were randomly selected by a researcher, a 10-fold reduction in workload was achieved versus that of manual screening based on the WSS@95% value, with high sensitivity for eligible studies. The area under the receiver operating characteristic curve increased dramatically every time the algorithm learned a correct article. CONCLUSIONS Concept Encoder achieved a 10-fold reduction of the screening workload for systematic review after learning from 2 randomly selected studies on the target topic. However, few meta-analyses of randomized controlled trials were included. Concept Encoder could facilitate the acquisition of evidence for clinical guidelines.
- 14 July 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDeep Neural Network for Reducing the Screening Workload in Systematic Reviews for Clinical Guidelines: Algorithm Validation Study (Preprint)
BACKGROUND Performing systematic reviews is a time-consuming and resource-intensive process. OBJECTIVE We investigated whether a machine learning system could perform systematic reviews more efficiently. METHODS All systematic reviews and meta-analyses of interventional randomized controlled trials cited in recent clinical guidelines from the American Diabetes Association, American College of Cardiology, American Heart Association (2 guidelines), and American Stroke Association were assessed. After reproducing the primary screening data set according to the published search strategy of each, we extracted correct articles (those actually reviewed) and incorrect articles (those not reviewed) from the data set. These 2 sets of articles were used to train a neural network–based artificial intelligence engine (Concept Encoder, Fronteo Inc). The primary endpoint was work saved over sampling at 95% recall (WSS@95%). RESULTS Among 145 candidate reviews of randomized controlled trials, 8 reviews fulfilled the inclusion criteria. For these 8 reviews, the machine learning system significantly reduced the literature screening workload by at least 6-fold versus that of manual screening based on WSS@95%. When machine learning was initiated using 2 correct articles that were randomly selected by a researcher, a 10-fold reduction in workload was achieved versus that of manual screening based on the WSS@95% value, with high sensitivity for eligible studies. The area under the receiver operating characteristic curve increased dramatically every time the algorithm learned a correct article. CONCLUSIONS Concept Encoder achieved a 10-fold reduction of the screening workload for systematic review after learning from 2 randomly selected studies on the target topic. However, few meta-analyses of randomized controlled trials were included. Concept Encoder could facilitate the acquisition of evidence for clinical guidelines.
- 6 January 2020
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 36 (3) , 403-409
Myocardial infarction in type 2 diabetes using sodium–glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning
Aims: Some hypoglycemic therapies were associated with lower risk of cardiovascular outcomes. We investigated the incidence of cardiovascular disease among patients with type 2 diabetes using antidiabetic drugs from three classes, which were sodium-glucose co-transporter-2 inhibitors (SGLT-2is), glucagon-like peptide-1 receptor agonists (GLP-1RAs), or dipeptidyl peptidase-4 inhibitors (DPP-4is). Materials and methods: We compared the risk of myocardial infarction (MI) among these drugs and developed a machine learning model for predicting MI in patients without prior heart disease. We analyzed US health plan data for patients without prior MI or insulin therapy who were aged ≥40 years at initial prescription and had not received oral antidiabetic drugs for ≥6 months previously. After developing a machine learning model to predict MI, proportional hazards analysis of MI incidence was conducted using the risk obtained with this model and the drug classes as explanatory variables. Results: We analyzed 199,116 patients (mean age: years), comprising 110,278 (58.6) prescribed DPP-4is, 43,538 (55.1) prescribed GLP-1RAs, and 45,300 (55.3) prescribed SGLT-2is. Receiver operating characteristics analysis showed higher precision of machine learning over logistic regression analysis. Proportional hazards analysis by machine learning revealed a significantly lower risk of MI with SGLT-2is or GLP-1RAs than DPP-4is (hazard ratio: 0.81, 95% confidence interval: 0.72-0.91, p = 0.0004 vs. 0.63, 0.56-0.72, p < 0.0001). MI risk was also significantly lower with GLP-1RAs than SGLT-2is (0.77, 0.66-0.90, p = 0.001). Limitations: All patients analyzed were covered by US commercial health plans, so information on patients aged ≥65 years was limited and the socioeconomic background may have been biased. Also, the observation period differed among the three classes of drugs due to differing release dates. Conclusions: Machine learning analysis suggested the risk of MI was 37% lower for type 2 diabetes patients without prior MI using GLP-1RAs versus DPP-4is, while the risk was 19% lower for SGLT-2is versus DPP-4is.
- 6 January 2020
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 36 (3) , 403-409
Myocardial infarction in type 2 diabetes using sodium–glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning
Aims: Some hypoglycemic therapies were associated with lower risk of cardiovascular outcomes. We investigated the incidence of cardiovascular disease among patients with type 2 diabetes using antidiabetic drugs from three classes, which were sodium-glucose co-transporter-2 inhibitors (SGLT-2is), glucagon-like peptide-1 receptor agonists (GLP-1RAs), or dipeptidyl peptidase-4 inhibitors (DPP-4is). Materials and methods: We compared the risk of myocardial infarction (MI) among these drugs and developed a machine learning model for predicting MI in patients without prior heart disease. We analyzed US health plan data for patients without prior MI or insulin therapy who were aged ≥40 years at initial prescription and had not received oral antidiabetic drugs for ≥6 months previously. After developing a machine learning model to predict MI, proportional hazards analysis of MI incidence was conducted using the risk obtained with this model and the drug classes as explanatory variables. Results: We analyzed 199,116 patients (mean age: years), comprising 110,278 (58.6) prescribed DPP-4is, 43,538 (55.1) prescribed GLP-1RAs, and 45,300 (55.3) prescribed SGLT-2is. Receiver operating characteristics analysis showed higher precision of machine learning over logistic regression analysis. Proportional hazards analysis by machine learning revealed a significantly lower risk of MI with SGLT-2is or GLP-1RAs than DPP-4is (hazard ratio: 0.81, 95% confidence interval: 0.72-0.91, p = 0.0004 vs. 0.63, 0.56-0.72, p < 0.0001). MI risk was also significantly lower with GLP-1RAs than SGLT-2is (0.77, 0.66-0.90, p = 0.001). Limitations: All patients analyzed were covered by US commercial health plans, so information on patients aged ≥65 years was limited and the socioeconomic background may have been biased. Also, the observation period differed among the three classes of drugs due to differing release dates. Conclusions: Machine learning analysis suggested the risk of MI was 37% lower for type 2 diabetes patients without prior MI using GLP-1RAs versus DPP-4is, while the risk was 19% lower for SGLT-2is versus DPP-4is.
- Open Access
- 15 December 2019
- Published by Springer Nature in Research Square
Predicting the dropout risk after treatment of obesity: Logistic regression analysis and deep neural network analysis
Backgrounds Severely obese patients must follow strict regimens of diet, exercise, and medical therapy. However, such comprehensive weight-loss programs have high dropout rates. In this study, we developed a machine learning prediction model to aid in the early detection of high-risk-dropout patients.Methods 102 severely obese patients were monitored for 3 years to assess their risk of dropout from a comprehensive weight-loss program. The program targeted a 5% weight loss. It consisted of three main components, which include behavioral modification (goal setting and charting weight four times daily), diet, and exercise. A machine learning model was developed to predict dropout risk based on a 1-year dropout event. To extend the prediction ability past 1 year, we plotted a 3-year Kaplan-Meier survival curve using a deep learning (DL) algorithm and logistic regression (LR) classifications.Results Their mean age was 49±14 years, 43% were male, BMI was 42 kg/m2, and hemoglobin A1c was 7.6%. Additionally, 76% had diabetes, 21% had impaired glucose tolerance. After 1 year, the dropout rate was 19%. Using oral hypoglycemic agents had a lower risk of 3-year dropout [Odds ratio 0.26 (95% CI: 0.08 to 0.83, p = 0.023)]. The area under the curve (AUC) was better with DL than LR methods for predicting dropout at 3 years (0.97 vs. 0.77, p<0.001). The AUC for DL was also better than LR using binary classifications (0.86 vs. 0.68, p=0.001).Conclusions We demonstrated a higher precision with machine learning than with the standard logistic regression, based on limited sample size and information available during hospital admission. It is vital to note that machine learning was more accurate than standard analysis. This may have clinical significance because machine learning could be used to identify high-risk groups and allow for early intervention.
- 15 December 2019
- Published by Springer Nature in Research Square
Open AccessPredicting the dropout risk after treatment of obesity: Logistic regression analysis and deep neural network analysis
Backgrounds Severely obese patients must follow strict regimens of diet, exercise, and medical therapy. However, such comprehensive weight-loss programs have high dropout rates. In this study, we developed a machine learning prediction model to aid in the early detection of high-risk-dropout patients.Methods 102 severely obese patients were monitored for 3 years to assess their risk of dropout from a comprehensive weight-loss program. The program targeted a 5% weight loss. It consisted of three main components, which include behavioral modification (goal setting and charting weight four times daily), diet, and exercise. A machine learning model was developed to predict dropout risk based on a 1-year dropout event. To extend the prediction ability past 1 year, we plotted a 3-year Kaplan-Meier survival curve using a deep learning (DL) algorithm and logistic regression (LR) classifications.Results Their mean age was 49±14 years, 43% were male, BMI was 42 kg/m2, and hemoglobin A1c was 7.6%. Additionally, 76% had diabetes, 21% had impaired glucose tolerance. After 1 year, the dropout rate was 19%. Using oral hypoglycemic agents had a lower risk of 3-year dropout [Odds ratio 0.26 (95% CI: 0.08 to 0.83, p = 0.023)]. The area under the curve (AUC) was better with DL than LR methods for predicting dropout at 3 years (0.97 vs. 0.77, p<0.001). The AUC for DL was also better than LR using binary classifications (0.86 vs. 0.68, p=0.001).Conclusions We demonstrated a higher precision with machine learning than with the standard logistic regression, based on limited sample size and information available during hospital admission. It is vital to note that machine learning was more accurate than standard analysis. This may have clinical significance because machine learning could be used to identify high-risk groups and allow for early intervention.
- Open Access
- 2 June 2019
- Published by PeerJ in PeerJ Preprints
PICO and Risk Of bias Navigator for Evidence Based Medicine
Evidence-based medicine (EBM) involves determining treatment that matches the needs of each patient by integrating the best and latest available “scientific evidence” and “clinical skills”. Systematic review and meta-analysis refer to the process of searching databases and performing statistical analysis to integrate the results of multiple independent studies conducted in the past. The results obtained provide the highest quality evidence, which has become the foundation of various clinical guidelines. Systematic review and meta-analysis are conducted in the following sequence: 1) formulation of a hypothesis, 2) searching databases for articles, 3) selection of research articles, 4) evaluation of bias for each study, 5) integration of the results, 6) verification of bias, and 7) evaluation of the quality of the meta-analysis. Especially regarding 2) article searches and 3) article selection, it is usual for two or more researchers to independently conduct a comprehensive search of databases and extract all the articles that meet the eligibility criteria. Generally, each researcher must evaluate thousands of research articles one by one, making the whole process very time-consuming. In addition, articles may be missed since the search is done manually, and the results tend to be arbitrary. Moreover, updating the information requires a lot of time and effort. Generally, it takes one to two years to complete a single systematic review and meta-analysis. As a result, many reviews are obsolete or missing. Therefore, development of software that could contribute to labor saving and automation of systematic review has been advocated. PICORON-EBM aims to shorten the time required for assessment of PICO and Risk of Bias by natural language processing. Strengths: 1. Quick and Easy operation. 2. You can add and delete any keywords to your area of interest. URL: http://www.picoron.com/
- 2 June 2019
- Published by PeerJ in PeerJ Preprints
Open AccessPICO and Risk Of bias Navigator for Evidence Based Medicine
Evidence-based medicine (EBM) involves determining treatment that matches the needs of each patient by integrating the best and latest available “scientific evidence” and “clinical skills”. Systematic review and meta-analysis refer to the process of searching databases and performing statistical analysis to integrate the results of multiple independent studies conducted in the past. The results obtained provide the highest quality evidence, which has become the foundation of various clinical guidelines. Systematic review and meta-analysis are conducted in the following sequence: 1) formulation of a hypothesis, 2) searching databases for articles, 3) selection of research articles, 4) evaluation of bias for each study, 5) integration of the results, 6) verification of bias, and 7) evaluation of the quality of the meta-analysis. Especially regarding 2) article searches and 3) article selection, it is usual for two or more researchers to independently conduct a comprehensive search of databases and extract all the articles that meet the eligibility criteria. Generally, each researcher must evaluate thousands of research articles one by one, making the whole process very time-consuming. In addition, articles may be missed since the search is done manually, and the results tend to be arbitrary. Moreover, updating the information requires a lot of time and effort. Generally, it takes one to two years to complete a single systematic review and meta-analysis. As a result, many reviews are obsolete or missing. Therefore, development of software that could contribute to labor saving and automation of systematic review has been advocated. PICORON-EBM aims to shorten the time required for assessment of PICO and Risk of Bias by natural language processing. Strengths: 1. Quick and Easy operation. 2. You can add and delete any keywords to your area of interest. URL: http://www.picoron.com/
- Open Access
- 2 June 2019
- Published by PeerJ in PeerJ Preprints
Automated data extraction software for medical summary using text mining (T-Library)
The electronic medical record (EMR) is a source of clinical information and is used for clinical research. Clinical researchers leverage this information by employing staffs to manually extracting data from the unstructured text. This process can be both error-prone and labor-intensive. This software (T-Library) is a software which automatically extracts key clinical data from patient records and can potentially help healthcare providers and researchers save money, make treatment decisions and manage clinical trials. This software saves labor for data transcription in clinical research. This is a vital step toward getting researchers rapid access to the information they need. This is also the attempt to cluster patients’ morbid states and establish accurate and constantly updated risk engine of complications’ crises, using deep learning. Strengths: 1) Quick and Easy operation URL: http://www.picoron.com/tlibrary/
- 2 June 2019
- Published by PeerJ in PeerJ Preprints
Open AccessAutomated data extraction software for medical summary using text mining (T-Library)
The electronic medical record (EMR) is a source of clinical information and is used for clinical research. Clinical researchers leverage this information by employing staffs to manually extracting data from the unstructured text. This process can be both error-prone and labor-intensive. This software (T-Library) is a software which automatically extracts key clinical data from patient records and can potentially help healthcare providers and researchers save money, make treatment decisions and manage clinical trials. This software saves labor for data transcription in clinical research. This is a vital step toward getting researchers rapid access to the information they need. This is also the attempt to cluster patients’ morbid states and establish accurate and constantly updated risk engine of complications’ crises, using deep learning. Strengths: 1) Quick and Easy operation URL: http://www.picoron.com/tlibrary/
- Open Access
- 2 June 2019
- Published by PeerJ in PeerJ Preprints
Automated data extraction software for medical summary using text mining (T-Library)
The electronic medical record (EMR) is a source of clinical information and is used for clinical research. Clinical researchers leverage this information by employing staffs to manually extracting data from the unstructured text. This process can be both error-prone and labor-intensive. This software (T-Library) is a software which automatically extracts key clinical data from patient records and can potentially help healthcare providers and researchers save money, make treatment decisions and manage clinical trials. This software saves labor for data transcription in clinical research. This is a vital step toward getting researchers rapid access to the information they need. This is also the attempt to cluster patients’ morbid states and establish accurate and constantly updated risk engine of complications’ crises, using deep learning. Strengths: 1) Quick and Easy operation URL: http://www.picoron.com/tlibrary/
- 2 June 2019
- Published by PeerJ in PeerJ Preprints
Open AccessAutomated data extraction software for medical summary using text mining (T-Library)
The electronic medical record (EMR) is a source of clinical information and is used for clinical research. Clinical researchers leverage this information by employing staffs to manually extracting data from the unstructured text. This process can be both error-prone and labor-intensive. This software (T-Library) is a software which automatically extracts key clinical data from patient records and can potentially help healthcare providers and researchers save money, make treatment decisions and manage clinical trials. This software saves labor for data transcription in clinical research. This is a vital step toward getting researchers rapid access to the information they need. This is also the attempt to cluster patients’ morbid states and establish accurate and constantly updated risk engine of complications’ crises, using deep learning. Strengths: 1) Quick and Easy operation URL: http://www.picoron.com/tlibrary/